Experimental liver shot aims to wake up immune system against colorectal cancer
NCT ID NCT07172282
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial is testing whether a drug called Nelitolimod, given directly into the liver through a special catheter, can safely boost the immune system in 10 people with colorectal cancer that has spread to the liver. Participants will receive the drug three times before their planned liver surgery. The main goal is to see if this approach is feasible and safe, not yet to prove it works against the cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nelitolimod
What this could lead to
If this works, it could point toward a new way to boost the immune system against colorectal cancer that has spread to the liver, potentially making surgery more effective.
What could go wrong
This is a very early, small study with only 10 people. It is designed mainly to check safety and feasibility, not to prove the treatment works. The drug may not produce a meaningful immune response or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
RJ Zuckerberg
RECRUITINGLake Success, New York, 11042, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••